Biliary Atresia: Clinical Trials

4 trials for Biliary Atresia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 22Completed 2

Follow Biliary Atresia: new trials by email Literature Review of Biliary Atresia trials Research Report on Biliary Atresia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia
Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation - Primary Biliary Cirrhosis
Phase 1 / Phase 2CompletedVinmec Research Institute of Stem Cell and Gene Technology202019-08-102024-06-06
Autologous BMNC Infusion for Liver Cirrhosis in Children With BA
Autologous BMMC transplantation - Biliary Atresia
Phase 1CompletedVinmec Research Institute of Stem Cell and Gene Technology122015-01-012022-08-26
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
Intravenous immunoglobulin (IVIG) - Biliary Atresia
Phase 1 / Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)302013-10-012026-10-01
Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Vancomycin - Primary Sclerosing Cholangitis, Biliary Atresia
Phase 1CompletedStanford University322007-05-012016-05-18

Narrower conditions

Cholangitis, Sclerosing (1)  ·  Liver Cirrhosis (1)  ·  Liver Cirrhosis, Biliary (1)

Broader conditions

Bile Duct Diseases (4)  ·  Biliary Tract Diseases (4)  ·  Congenital Abnormalities (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Digestive System Abnormalities (4)  ·  Digestive System Diseases (4)  ·  Cholangitis (1)  ·  Cholestasis (1)  ·  Cholestasis, Intrahepatic (1)  ·  Fibrosis (1)  ·  Liver Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Hizentra (1)  ·  Immunoglobulins, Intravenous (1)  ·  Transplantation (1)  ·  Vancomycin (1)

Sponsors

Vinmec Research Institute of Stem Cell and Gene Technology (2)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Stanford University (1)

Countries

Vietnam (2)  ·  Canada (1)  ·  United States (1)

Top investigators

Averell Sherker, MD (1)  ·  Ed Doo, MD (1)  ·  Kenneth L Cox, MD (1)  ·  Liem Nguyen (1)  ·  Liem Thanh Nguyen, PhD (1)  ·  Ronald Sokol, MD (1)

Results publications

PMID 23054338, PMID 30664564, PMID 32633158, PMID 39568009, PMID 40907882

NIH funding

U01DK062456 (1)